Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity.
Biomarkers
Cell Line
Cytomegalovirus
/ immunology
Cytomegalovirus Infections
/ immunology
Female
Fibroblasts
/ immunology
Humans
Immunocompromised Host
Interferon-gamma
/ biosynthesis
Kidney Transplantation
Lymphocyte Activation
Male
Middle Aged
Receptors, Antigen, T-Cell, gamma-delta
/ immunology
Severity of Illness Index
T-Lymphocyte Subsets
/ immunology
CMV infection
gamma-delta T cells
kidney transplant recipients
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
24 02 2021
24 02 2021
Historique:
received:
31
03
2020
accepted:
02
07
2020
pubmed:
6
7
2020
medline:
6
11
2021
entrez:
5
7
2020
Statut:
ppublish
Résumé
Cytomegalovirus (CMV) is a major infectious cause of death and disease after transplantation. We have previously demonstrated that the tissue-associated adaptive Vδ2neg γδ T cells are key effectors responding to CMV and associated with recovery, contrasting with their innatelike circulating counterparts, the Vγ9posVδ2pos T cells that respond to phosphoantigens but not to CMV. A third Vγ9negVδ2pos subgroup with adaptive functions has been described in adults. In the current study, we demonstrate that these Vγ9negVδ2pos T cells are also components of the CMV immune response while presenting with distinct characteristics from Vδ2neg γδ T cells. In a cohort of kidney transplant recipients, CMV seropositivity was the unique clinical parameter associated with Vγ9negVδ2pos T-cell expansion and differentiation. Extensive phenotyping demonstrated their substantial cytotoxic potential and activation during acute CMV primary infection or reinfection. In vitro, Vγ9negVδ2pos T cells responded specifically to CMV-infected cells in a T-cell receptor-dependent manner and through strong interferon γ production. Finally, Vγ9negVδ2pos T cells were the only γδ T-cell subset in which expansion was tightly correlated with the severity of CMV disease. To conclude, our results identify a new player in the immune response against CMV and open interesting clinical perspectives for using Vγ9negVδ2pos T cells as an immune marker for CMV disease severity in immunocompromised patients.
Identifiants
pubmed: 32622351
pii: 5867506
doi: 10.1093/infdis/jiaa400
doi:
Substances chimiques
Biomarkers
0
Receptors, Antigen, T-Cell, gamma-delta
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
655-666Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.